| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J7677 |
Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram |
12,436 |
7,678 |
$1.26M |
| J7606 |
Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms |
6,259 |
5,320 |
$462K |
| J7605 |
Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms |
4,050 |
3,434 |
$228K |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
9,743 |
8,209 |
$145K |
| Q0513 |
Pharmacy dispensing fee for inhalation drug(s); per 30 days |
14,636 |
12,171 |
$105K |
| J7699 |
Noc drugs, inhalation solution administered through dme |
388 |
329 |
$37K |
| G0333 |
Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary |
991 |
812 |
$11K |
| E0570 |
Nebulizer, with compressor |
3,971 |
3,893 |
$9K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
2,545 |
2,140 |
$6K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
3,544 |
3,075 |
$5K |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
4,426 |
3,873 |
$2K |
| A7005 |
Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable |
299 |
259 |
$686.20 |
| A7015 |
Aerosol mask, used with dme nebulizer |
1,476 |
1,263 |
$209.39 |
| A7013 |
Filter, disposable, used with aerosol compressor or ultrasonic generator |
782 |
652 |
$65.55 |